The Association between Serum Biomarkers and Disease Outcome in Influenza A(H1N1)pdm09 Virus Infection: Results of Two International Observational Cohort Studies

Davey Jr, Richard T.; Lynfield, Ruth; Dwyer, Dominic E.; Losso, Marcello H.; Cozzi-Lepri, Alessandro; Wentworth, Deborah; Lane, H. Clifford; Dewar, Robin; Rupert, Adam; Metcalf, Julia A.; Pett, Sarah L.; Uyeki, Timothy M.; Bruguera, Jose Maria; Angus, Brian; Cummins, Nathan; Lundgren, Jens; Neaton, James D.
February 2013
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
Academic Journal
Background: Prospective studies establishing the temporal relationship between the degree of inflammation and human influenza disease progression are scarce. To assess predictors of disease progression among patients with influenza A(H1N1)pdm09 infection, 25 inflammatory biomarkers measured at enrollment were analyzed in two international observational cohort studies. Methods: Among patients with RT-PCR-confirmed influenza A(H1N1)pdm09 virus infection, odds ratios (ORs) estimated by logistic regression were used to summarize the associations of biomarkers measured at enrollment with worsened disease outcome or death after 14 days of follow-up for those seeking outpatient care (FLU 002) or after 60 days for those hospitalized with influenza complications (FLU 003). Biomarkers that were significantly associated with progression in both studies (p<0.05) or only in one (p<0.002 after Bonferroni correction) were identified. Results: In FLU 002 28/528 (5.3%) outpatients had influenza A(H1N1)pdm09 virus infection that progressed to a study endpoint of complications, hospitalization or death, whereas in FLU 003 28/170 (16.5%) inpatients enrolled from the general ward and 21/39 (53.8%) inpatients enrolled directly from the ICU experienced disease progression. Higher levels of 12 of the 25 markers were significantly associated with subsequent disease progression. Of these, 7 markers (IL-6, CD163, IL-10, LBP, IL-2, MCP-1, and IP-10), all with ORs for the 3rd versus 1st tertile of 2.5 or greater, were significant (p<0.05) in both outpatients and inpatients. In contrast, five markers (sICAM-1, IL-8, TNF-α, D-dimer, and sVCAM-1), all with ORs for the 3rd versus 1st tertile greater than 3.2, were significantly (p≤.002) associated with disease progression among hospitalized patients only. Conclusions: In patients presenting with varying severities of influenza A(H1N1)pdm09 virus infection, a baseline elevation in several biomarkers associated with inflammation, coagulation, or immune function strongly predicted a higher risk of disease progression. It is conceivable that interventions designed to abrogate these baseline elevations might affect disease outcome.


Related Articles

  • Noninvasive Serum Fibrosis Markers for Screening and Staging Chronic Hepatitis C Virus Patients in a Large US Cohort. Holmberg, Scott D.; Lu, Mei; Rupp, Loralee B.; Lamerato, Lois E.; Moorman, Anne C.; Vijayadeva, Vinutha; Boscarino, Joseph A.; Henkle, Emily M.; Gordon, Stuart C. // Clinical Infectious Diseases;Jul2013, Vol. 57 Issue 2, p240 

    Authors review 2 (FIB-4 and APRI) systems relying on more easily obtainable serum and cell biomarkers for liver biopsies to stage liver disease. This would be an important step in opening treatment and care of uncomplicated hepatitis C virus–infected patients.Background. Liver biopsy...

  • Changes in pre-diagnostic serum C-reactive protein concentrations and ovarian cancer risk: a longitudinal study. Toriola, A. T.; Grankvist, K.; Agborsangaya, C. B.; Lukanova, A.; Lehtinen, M.; Surcel, H.-M. // Annals of Oncology;Aug2011, Vol. 22 Issue 8, p1916 

    Background: Evidence suggests that inflammation may be associated with increased risk of ovarian cancer but there is paucity of studies investigating this association, especially using over-time changes in inflammatory biomarkers.Materials and methods: We conducted a prospective population-based...

  • Non-Avian Animal Reservoirs Present a Source of Influenza A PB1-F2 Proteins with Novel Virulence-Enhancing Markers. Alymova, Irina V.; York, Ian A.; McCullers, Jonathan A. // PLoS ONE;Nov2014, Vol. 9 Issue 11, p1 

    PB1-F2 protein, expressed from an alternative reading frame of most influenza A virus (IAV) PB1 segments, may possess specific residues associated with enhanced inflammation (L62, R75, R79, and L82) and cytotoxicity (I68, L69, and V70). These residues were shown to increase the pathogenicity of...

  • Inflammatory Factors and Exercise in Chronic Kidney Disease. Dungey, Maurice; Hull, Katherine L.; Smith, Alice C.; Burton, James O.; Bishop, Nicolette C. // International Journal of Endocrinology;2013, p1 

    Patients with chronic kidney disease frequently present with chronic elevations in markers of inflammation, a condition that appears to be exacerbated by disease progression and onset of haemodialysis. Systemic inflammation is interlinked with malnutrition and muscle protein wasting and is...

  • Salivary α-synuclein and DJ-1: potential biomarkers for Parkinson's disease. Devic, Ivana; Hwang, HyeJin; Edgar, John Scott; Izutsu, Kenneth; Presland, Richard; Pan, Catherine; Goodlett, David R.; Wang, Yu; Armaly, Jeff; Tumas, Vitor; Zabetian, Cyrus P.; Leverenz, James B.; Shi, Min; Zhang, Jing // Brain: A Journal of Neurology;Jul2011, Vol. 134 Issue 7, pe178 

    No abstract available.

  • Herpes simplex virus type 2 and HIV disease progression: a systematic review of observational studies. Hoi-San Tan, Darrell; Murphy, Kellie; Shah, Prakesh; Walmsley, Sharon Lynn // BMC Infectious Diseases;2013, Vol. 13 Issue 1, p1 

    Background Herpes simplex virus type 2 (HSV-2) is a common co-infection among HIV-infected adults that is hypothesized to accelerate HIV disease progression. Methods We searched Medline, EMBASE, relevant conference proceedings (2006-12) and bibliographies of identified studies without language...

  • Serial measurements of midregion proANP and copeptin in ambulatory patients with heart failure: incremental prognostic value of novel biomarkers in heart failure. Miller, Wayne L.; Hartman, Karen A.; Grill, Diane E.; Struck, Joachim; Bergmann, Andreas; Jaffe, Allan S. // Heart;Mar2012, Vol. 98 Issue 5, p389 

    Background Disease progression in heart failure (HF) reflects derangements in neurohormonal systems, and biomarkers of these systems can help to establish the diagnosis and assess the prognosis. Serial measurements of the precursor peptides of the natriuretic and vasopressin systems (midregional...

  • RePORT International: Advancing Tuberculosis Biomarker Research Through Global Collaboration. Hamilton, Carol D.; Swaminathan, Soumya; Christopher, Devasahayam J.; Ellner, Jerrold; Gupta, Amita; Sterling, Timothy R.; Rolla, Valeria; Srinivasan, Sudha; Karyana, Muhammad; Siddiqui, Sophia; Stoszek, Sonia K.; Kim, Peter // Clinical Infectious Diseases;2015 Supplement 3, Vol. 61, pS155 

    Progress in tuberculosis clinical research is hampered by a lack of reliable biomarkers that predict progression from latent to active tuberculosis, and subsequent cure, relapse, or failure. Regional Prospective Observational Research in Tuberculosis (RePORT) International represents a...

  • CoReumaPt Protocol: the Portuguese Cohort of Rheumatic Diseases. Laires, Pedro A.; Canhão, Helena; Araújo, Domingos; Fonseca, João Eurico; Machado, Pedro; Mourão, Ana Filipa; Ramiro, Sofia; Romeu, José Carlos; Santos, Maria José; Silva, Inês; Silva, José A. Pereira; Sousa, Elsa; Tavares, Viviana; Gouveia, Nélia; Branco, Jaime C. // Acta Reumatológica Portuguesa;jan-mar2012, Vol. 37 Issue 1, p18 

    Introduction: Rheumatic diseases (RD) are conditions with a variety of clinical manifestations and prognosis influenced by several factors. Cohorts and registries have been already established in some countries and have contributed to important knowledge about the disease course and the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics